OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma
Yiqing Zang, Qiuping Dong, Yi Lü, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 4388-4408
Open Access | Times Cited: 15

Showing 15 citing articles:

Lumican in Carcinogenesis—Revisited
Eirini-Maria Giatagana, Aikaterini Berdiaki, Aristidis Tsatsakis, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1319-1319
Open Access | Times Cited: 41

Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment
Yingru Zhang, Yiyang Zhao, Qi Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32

Network pharmacology and molecular docking to elucidate the mechanism of pulsatilla decoction in the treatment of colon cancer
Huan Liu, Yuting Hu, Baoyu Qi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor relapse
Ana Martínez‐Val, Leander van der Hoeven, Dorte B. Bekker‐Jensen, et al.
Molecular Systems Biology (2025)
Open Access

Chaperone-Mediated Autophagy Ablation in Pericytes Reveals New Glioblastoma Prognostic Markers and Efficient Treatment Against Tumor Progression
M. Molina, David García‐Bernal, M. Salinas, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12

Matrix proteoglycans in tumor inflammation and immunity
Gauri Deb, Alexander Cicala, Athanasios Papadas, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 3, pp. C678-C693
Open Access | Times Cited: 11

Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting
Geyang Dai, Yue Sun, Rui Wei, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 7, pp. 6116-6139
Open Access | Times Cited: 5

Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis
M. Salinas, Pablo Rodriguez, Gonzalo Rubio, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 192-192
Open Access | Times Cited: 1

Multi-omics analysis reveals the prognostic and tumor micro-environmental value of lumican in multiple cancer types
Zehuai Guo, Zeyun Li, Ming Chen, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3

Proteomics of colorectal tumors identifies the role of CAVIN1 in tumor formation and progression
Jesper V. Olsen, Ana Martínez‐Val, Leander van der Hoeven, et al.
Research Square (Research Square) (2024)
Open Access

Lumican is a potential predictor on the efficacy of concurrent chemoradiotherapy in cervical squamous cell carcinoma
Ge Hu, Ying Xiao, Chanchan Ma, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18011-e18011
Open Access | Times Cited: 1

Page 1

Scroll to top